We help our pharma clients navigate through complex regulatory frameworks related to diagnostic testing in the development, commercialization and post-commercialization phases.

  • We can track the dynamic regulatory environment in each target market;
  • Utilize a team of global experts to understand the impact of new regulations on diagnostic commercialization;
  • Advise on how diagnostics and new technology can be commercialized under evolving regulatory policies.